Get the latest news on Bio Essence stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on BIOE performance

Latest Bio Essence Stock News | OTC:BIOE | Benzinga

Bio Essence Corp is an herbal health, diet, and nutrition company. The Company's mission is to provide herbal health, diet, and vitamin nutritional supplements. The company is focused on producing health products along with providing original equipment manufacturing and private label services to other companies. The company develops traditional Chinese medicines (TCM) in the form of single herbs, granules, pills, and tablets. The company also offers special formulated dietary supplements and medical food.

Penny,Stock,Investments,Taking,Off,Concept

Long Ideas

News

Penny Stocks

Insider Trades

Pre-Market Outlook

Markets

Trading Ideas

BIOE

CATX

EXFY

Expensify And 2 Other Stocks Under $2 Insiders Are Buying

Bio Essence Corp

BioELife Corp

BIOELECTRONICS CORP by BioElectronics Corp.

Bioelectronics Corp

Bioethics Ltd

Bio Essence

The Dow Jones index closed lower by over 100 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#8217;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.



Below is a look at a few recent notable insider transactions for penny stocks. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.



<h3 class="wp-block-heading">Expensify</h3>



<ul>
<li>The Trade: Expensify, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EXFY#NASDAQ">EXFY</a>) Director Timothy L Christen <a href="https://www.benzinga.com/sec/insider-trades/">bought a total of 19,162 shares</a> at an average price of $1.61. To acquire these shares, it cost around $30,851.</li>



<li>What's Happening: On May 9, Expensify posted downbeat quarterly results.</li>



<li>What Expensify Does: Expensify Inc is a cloud-based expense management software platform that helps various businesses simplify the way to manage money.</li>
</ul>



<h3 class="wp-block-heading">Bio Essence</h3>



<ul>
<li>The Trade: Bio Essence Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BIOE#OTC">BIOE</a>) CEO Yin Yan <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 5,000,000 shares</a> at an average price of $0.50. To acquire these shares, it cost around $2.5 million.</li>



<li>What's Happening: The company&#8217;s stock jumped around 127% over the past month.</li>



<li>What Bio Essence Does: Bio Essence Corp is an herbal health, diet, and nutrition company. The Company&#8217;s mission is to provide herbal health, diet, and vitamin nutritional supplements.</li>
</ul>



<h3 class="wp-block-heading">Perspective Therapeutics</h3>



<ul>
<li>The Trade: Perspective Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CATX#NASDAQ">CATX</a>) CFO Jonathan Robert Hunt <a href="https://www.benzinga.com/sec/insider-trades/">acquired a total of 25,006 shares</a> at an average price of $1.40. The insider spent around $35,007 to buy those shares. The company's Director Robert F Williamson III also bought 55,000 shares of the company.</li>



<li>What's Happening: On May 24, Perspective Therapeutics announced the pricing of $80 million underwritten offering of common stock and pre-funded warrants.</li>



<li>What Perspective Therapeutics Does: Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body.</li>
</ul>



Now Read This: <a href="https://www.benzinga.com/news/24/06/39135431/top-3-utilities-stocks-that-may-plunge-in-q2">Top 3 Utilities Stocks That May Plunge In Q2</a>

Comments

Bio Essence Stock News

News

Latest Bio Essence Stock News | OTC:BIOE | Benzinga

Tuesday, June 04, 2024

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga